Zensar Technologies Share Price Rises Nearly 3% After ESOP Share Allotment Update
By HDFC SKY | Published at: Mar 10, 2026 03:58 PM IST
Zensar Technologies shares rose nearly 3% on March 10, 2026, after the company announced the allotment of 64,051 equity shares under its ESOP scheme, slightly increasing its issued share capital.

Mumbai, March 10: Share price of Zensar Technologies Ltd rose in Tuesday’s trading session after the company disclosed an equity share allotment under its employee stock option plan (ESOP). The stock was trading at ₹560.50, up ₹16.15 or 2.97%, as of 1:42 PM IST on March 10, 2026, compared with its previous close of ₹544.35 on the NSE.
During the session so far, the stock opened at ₹546.95 and touched a high of ₹561.90. The move followed a regulatory disclosure confirming a fresh allotment of equity shares to employees under exercised stock options.
Why The Share Price Moved
Zensar Technologies informed stock exchanges through a regulatory filing dated March 9, 2026, that the Nomination and Remuneration Committee approved the allotment of 64,051 fully paid equity shares with a face value of ₹2 each to employees who exercised vested ESOPs.
Following the allotment, the company’s issued and subscribed share capital increased to ₹454,988,908, divided into 227,494,454 equity shares of ₹2 each, according to the filing signed by Company Secretary Anand Daga.
ESOP exercises typically expand the company’s equity base marginally while aligning employee incentives with shareholder performance. The market reaction appeared measured, with the stock edging higher during trading after the disclosure.
Stock Performance Snapshot
As of 1:42 PM IST on March 10, 2026, Zensar Technologies shares were trading at ₹560.50, marking a gain of nearly 3% for the day so far.
So far in the session, the stock has moved within a ₹546.95–₹561.90 range. The company currently commands a market capitalisation of about ₹12.72K crore with a price-to-earnings ratio of 17.40, based on exchange data visible during the session.
Over the longer term, the stock’s 52-week high stands at ₹894.00, while the 52-week low is ₹528.25.
What This Means For Investors
The allotment represents a routine ESOP exercise rather than a capital-raising event. Such issuances generally cause minimal equity dilution because the number of shares added relative to the overall capital base remains small.
For investors, the update primarily signals the continued utilisation of employee incentive plans. ESOP frameworks are commonly used by technology firms to retain skilled employees and align management performance with shareholder value creation.
That said, investors typically track cumulative ESOP issuance over time to evaluate potential dilution and compensation structures.
Broader Market And Sectoral Context
The IT services sector has recently seen moderate investor attention amid expectations of stabilising global technology spending. Mid-tier IT firms, including Zensar Technologies, often experience trading volatility around corporate disclosures such as management commentary, contract wins, or capital structure updates.
In contrast to earnings announcements or large order wins, ESOP-related filings usually have limited direct impact on fundamentals, though they can still trigger short-term market reactions due to increased disclosure visibility.
About The Company
Zensar Technologies Ltd is an India-based information technology services and consulting company. The firm provides digital transformation solutions across industries including manufacturing, retail, financial services, and healthcare.
The company operates globally and focuses on areas such as application services, experience design, data engineering, and cloud infrastructure. Zensar is part of the RPG Group and serves enterprise clients across North America, Europe, and Asia.
Conclusion
Zensar Technologies’ shares moved higher during the March 10 2026 trading session following confirmation of a 64,051-share ESOP allotment approved on March 9 2026. While the issuance slightly expanded the company’s equity base, the scale of dilution remains limited relative to its overall capital structure. For now, the disclosure appears to have prompted a modest positive reaction in the stock without altering the company’s broader operational outlook.
Source:
- https://www.nseindia.com/get-quote/equity/ZENSARTECH/Zensar-Technologies-Limited
- https://nsearchives.nseindia.com/corporate/ZENSARTECH_09032026210024_Stock_Exchange_intimation.pdf
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations

